Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: Steven Messina,L.M.T. who wrote (31640)	12/7/1998 9:01:00 PM
From: pitchlyn	Respond to of 34592

Check out BNEZ. Double-bottom at .23 cents with increasing volume and ask. Hasn't taken off YET but looks poised to pop SOON. Here's a post from Yahoo which basically agrees with my summation: post.messages.yahoo.com. BNEZ about to EXPLODE from its base .20 cents! by: __BreakOut__ Investment Software company targeting both business as well as individual investor's needs. Stock wound very tight and ready to pop. Notice increasing volume and Double-Bottom formation: tscn.com. Its PMA (Personal Market Analyst), created for Inc. Magazine, is the type of program that YOU (i.e., those of you reading this) just might be interested in (seriously): benez.com There is an abundance of info about this company out there so DD shouldn't be difficult. "Confidence" as opposed to "hype" is the sense I get from reading the various threads: SI: Subject 11075 Raging Bull: ragingbull.com Looks good to me!

To: Steven Messina,L.M.T. who wrote (31640)	12/14/1998 1:07:00 PM
From: RCJIII	Read Replies (1) \| Respond to of 34592

Buying VGCP, major financing deal to be announced very soon will allow them to close on the purchase of their first insurance company and allow them to debut their new proprietary internet software for the insurance industry. It provides interactive internet account access as well as links to the best and latest research, treatment options, specialists, etc. for each patient's specific illness. Financing PR should send the stock much higher near term. RCJIII